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Available online 13 August 2016Background: The main focus of studies of individuals at ultra-high risk for psychosis (UHR) has been on identify-
ing brain changes in those individuals who will develop psychosis. However, longitudinal studies have shown
that up to half of UHR individuals are resilient, with symptomatic remission and good functioning at follow-
up. Yet little is known about brain development in resilient individuals. Therefore, the aim of this study was to
investigate differences in brain development between resilient and non-resilient individuals.
Methods: A six-year longitudinal structural MRI study was performed with up to three scans per individual. The
ﬁnal sample consisted of 48 UHR individuals and 48 typically developing controls with a total of 225 MRI-scans,
aged12–20 years at the time of theﬁrstMRI-scan andmatched for age, gender and number of follow-up scans. At
six-year follow-up, 35 UHR individuals were divided in resilient (good functional outcome) and non-resilient
(poor functional outcome) subgroups, deﬁned by themodiﬁed Global Assessment of Functioning. Themain out-
come measures were developmental changes in MR-based measures of cortical and subcortical anatomy.
Results:We found widespread differences in volume of frontal, temporal and parietal cortex between resilient
and non-resilient individuals. These were already present at baseline and remained stable over development
(12–24 years). Furthermore, therewere differences in the development of cortical surface area in frontal regions
including cingulate gyrus.
Conclusions:Developmental differencesmay reﬂect compensatory neuralmechanisms, where better functioning
in resilient individuals leads to less tissue loss over development.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Traditionally, studies of individuals at ultra-high risk (UHR) for psy-
chosis have attempted to identify neurobiological markers to predict
which UHR individuals will go on to develop psychosis (i.e. undergo a
‘transition to psychosis’). Thus, the ﬁeld has focused on identifying dif-
ferences in the brains of those subjects whowill worsen over time com-
pared to thosewhowill not. However, transition rates have plummeted
since the earliest reports of rates of over 50% (Miller et al., 2002) to an
average of 29% in more recent reports (Fusar-Poli et al., 2012a). At the
same time, there has been a steady increase in the remission rates re-
ported, of up to 54% (Simon et al., 2011). A recent meta-analysis of
eight longitudinal studies (Simon et al., 2013) reported that 73% ofPsychiatry, University Medical
(B01.108), Heidelberglaan 100,
. This is an open access article under773 UHR subjects did not develop psychosis over a 2-year follow-up
and 46% fully remitted from their baseline symptoms. We conducted a
longer follow-up,with ameanof six years, and found that 41%of adoles-
cents at UHR fully remitted from their at-risk state (deWit et al., 2014).
Therefore, it is at least as relevant to investigate neurobiological changes
in UHR subjects who show resilience and go on to function well, as it is
to investigate those who undergo a transition to psychosis.
In addition, the criterion of ‘transition to psychosis’ has been criti-
cized as a measure to identify which individuals will have a truly poor
clinical outcome: the threshold for transition is essentially arbitrary
and is based entirely on positive symptoms (Fusar-Poli et al., 2013;
Ziermans et al., 2014). There is increasing evidence that negative symp-
toms and the level of cognitive and social functioning are equally impor-
tant for the long-term outcome of UHR individuals (Fusar-Poli and
Borgwardt, 2007; Carrión et al., 2013; Fusar-Poli et al., 2013). Moreover,
some individuals may develop psychosis before going on to recover
completely, while some individuals who do not develop psychosis
may have worse outcomes (Yung et al., 2010; Fusar-Poli and Van Os,
2013; Cotter et al., 2014; de Wit et al., 2014). Taken together, thisthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Demographic data for typically developing controls (TDC) and UHR individuals.
TDC UHR UHR vs.
TDC
Number of individuals, n (males) 48 (29) 48 (29) n.s.
Hand preference, n,
right/non-right
40/8 44/4 n.s.
Parental education, years, mean
(SD)
Mother 13.45 (2.39) 12.96 (2.16) n.s.
Father 14.22 (2.17) 13.74 (2.18) n.s.
Premorbid IQ, mean (SD) 107.04 (13.12) 100.40 (11.97) t=
2.85,
p=
0.01
Age at baseline scan, years
Mean (SD) 15.72 (1.54) 15.43 (2.11) n.s.
Range 12.19–18.76 12.28–19.64
Age at 6-year FU scan, years
Mean (SD) 21.40 (1.57) 21.16 (2.42) n.s.
Range 17.57–24.54 16.84–25.79
Intra Cranial Volume (mm3) 1,621,000
(148220)
1,586,000
(167740)
n.s.
Number of scans, n n.a.
Total number of scans, n 103 122
1 48 48
2 24 39
3 31 35
Notes: TDC= typically developing controls; UHR= Individuals at ultra-high risk for psy-
chosis; IQ = intelligence quotient; SD = standard deviation; FU = follow-up.
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to psychosis. We follow the American Psychological Associate in deﬁn-
ing resilience as “the process of adapting well in the face of adversity, trau-
ma, tragedy, threats or signiﬁcant sources of stress — such as family and
relationship problems, serious health problems or workplace and ﬁnancial
stressors. It means “bouncing back” from difﬁcult experiences.”We there-
fore focus on how well individuals function at follow-up, rather than
whether they have experienced a transition to psychosis and
operationalise resilience as having good functional outcome. To permit
comparison to the extant literature, we also perform complementary
analyses using the more traditional operationalisation based on remis-
sion of positive symptoms (included as Supplemental material).
Compared to a volunteer sample of typically developing controls,
UHR individuals have been reported to show reduced gray matter vol-
ume in the frontal and temporal lobes, anterior cingulate gyrus and hip-
pocampal regions. (for reviews, see Fusar-Poli et al., 2011; Wood et al.,
2013; Bois et al., 2014). However, many imaging studies of UHR individ-
uals have been cross-sectional in design and have therefore been limit-
ed in their ability to show developmental differences between UHR
individuals with different outcomes. The longitudinal studies that
have been conductedwere only partially successful in predicting transi-
tion to psychosis and have reported many inconsistent ﬁndings (for re-
view, see Wood et al., 2013). This may in part be related to limited
follow-up times and differences in the methods used (Wood et al.,
2013), but is likely also related to the diverse clinical outcomes of UHR
individuals and the relatively arbitrary criterion of transition to psycho-
sis (deWit et al., 2014). One recent study of particular interest is that of
Cropley et al. (2016): in subjects with attenuated positive symptoms,
reduced gray matter volume was associated with more severe positive,
negative and depressive symptoms and lower global functioning in the
UHR subgroup without transition to psychosis. Unfortunately however,
there is a lack of studies investigating brain development with MRI
scans at different time points.
Therefore, we investigated brain development in resilient versus
non-resilient UHR individuals over, on average, six years.We conducted
a comprehensive assessment of symptoms and functioning and exam-
ined brain development, with MRI scans at three different time points.
This study includes a long follow-up of six years and more than two
MRI scans per individual. This permits a better assessment of outcome
and non-linear modeling of developmental trajectories.
2. Methods and materials
2.1. Participants
All data were collected at the Department of Psychiatry at the Uni-
versityMedical Center Utrecht, Brain Center RudolfMagnus in theNeth-
erlands. Participantswere between 12 and 18 years of age at the time of
recruitment and were included after written informed consent. The
study was approved by the Dutch Central Committee on Research In-
volving Human Subjects.
Recruitment details have been described previously (Sprong et al.,
2008; Ziermans et al., 2011). Brieﬂy, adolescents at UHR were referred
by general practitioners or other psychiatry clinics. For inclusion at
baseline, subjects in the UHR group had to fulﬁll at least one of the fol-
lowing criteria: 1) attenuated positive symptoms, 2) brief, limited, or in-
termittent psychotic symptoms, 3) genetic risk for psychosis combined
with a deterioration in overall level of social, occupational/school, and
psychological functioning in the past year or 4) two or more of nine
basic symptoms of mild cognitive disturbances. The ﬁrst three inclusion
criteria were assessed using the Structured Interview for Prodromal
Syndromes (McGlashan et al., 2001) and the Family Interview for Ge-
netic Studies (Maxwell, 1982). The fourth inclusion criterion was
assessed using the Bonn Scale for the Assessment of Basic Symptoms-
Prediction List that was assessed by a clinical expert (TZ) working
with child populations (Schultze-Lutter and Klosterkötter, 2002).Exclusion criteria consisted of a past or present psychotic episode last-
ingmore than oneweek, traumatic brain injury or any knownneurolog-
ical disorder, and verbal intellectual IQ b 75, as assessed using the
Wechsler Intelligence Scales by one of the co-authors (TZ) as well as
fully trained research assistants. (Wechsler, 1997, 2002). The typically
developing control group consisted of typically developing adolescents
recruited through secondary schools in the region of Utrecht. They
were excluded if theymet one of theUHR-criteria, if they or any ﬁrst de-
gree relative had a history of a psychiatric illness, or if they had a sec-
ond-degree relative with a psychotic disorder.
At baseline, 64 UHR individuals and 62 typically developing controls
completed the clinical assessment and an MRI scan. These groups were
thenmatched for gender, age, and number of follow-up scans, resulting
in a longitudinal dataset of 48UHR individuals and 48 typically develop-
ing controls with one, two or three scans and a total of 225 MRI scans.
Participants were between 12,2 and 19,6 years of age at the time of
the ﬁrst MRI scan (Table 1). Follow-up assessments were conducted
9 months, 18 months, 2 years, and 6 years post baseline (range 3,5–
8,0 years). The follow-ups at 9 and 18months only included clinical as-
sessments. For an overview of the timeline, see Fig. 1. We split the UHR
group into two groups based on the 6-year clinical follow-up data, one
‘resilient’ and one ‘non-resilient’ subgroup. Clinical outcome was avail-
able for 35 UHR individuals at 6 year follow up. Resilience was deﬁned
by functional outcome using the modiﬁed Global Assessment of Func-
tioning (mGAF) scale (Hall, 1995) as either a) Good functional outcome
(resilient): mGAF score of ≥65 or b) Poor functional outcome (non-re-
silient): mGAF score of b65. The cut off of 65 has been used before
(Allen et al., 2014) and was chosen as the 60–70 range corresponds to
‘generally good function with meaningful interpersonal relationships,
and some persistent mild symptoms and/or some persistent difﬁculty
in social, occupational, or school functioning’ (Hall, 1995). A score
below 60 indicates ‘moderate to severe symptoms and/or moderate to
severe difﬁculty in social, work, or school functioning,’ while scores
above 70 correspond to ‘some transient mild symptoms to absent or
minimal symptoms and/or slight to no impairment in social, work, or
school functioning’.
To make our results comparable to the existing literature we includ-
ed an extra analysis in our supplemental material, where we used the
Fig. 1. Timeline of the study. The top bar shows the time points at which individuals had a clinical assessment and/or MRI scanning session, at 0, 9, 18, 24 and 72 months follow-up. The
number of individuals included at baseline and follow up are displayed for the typical developing control group (middle) and UHR individuals (bottom). At six-year follow up, 17
individuals were deﬁned as resilient and 18 individuals as non-resilient.
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criteria (McGlashan et al., 2001), comparing individuals whohad remit-
ted from UHR criteria and individuals who had not. Further details on
both subgroupings are provided in Supplemental information S1.
2.2. Image acquisition
MRI scans were acquired on a single 1.5-T scanner at all time points
(Philips, Best, The Netherlands). Whole brain T1-weighted three-di-
mensional fast ﬁeld echo scans were made with 1.5-mm contiguous
coronal slices of the whole head (256 × 256 matrix, FoV = 256 mm,
echo time (TE) = 4.6 ms, repetition time (TR) = 30 ms, ﬂip angle =
30°).
2.3. Image processing
Scans were processed and analyzed using FreeSurfer v 5.1.0 soft-
ware. Technical details of the automated reconstruction scheme of this
well-validated software program are described elsewhere (Dale et al.,
1999; Fischl et al., 1999; Carmona et al., 2009). We calculated average
volume (mm3), cortical thickness (mm), surface area (mm2), and
gyriﬁcation for the 34 cortical structures in each hemisphere from the
Desikan-Killiany atlas (Desikan et al., 2006), aswell as cortical thickness
and surface area for each lobe and the whole brain, and total gray and
white matter volume per hemisphere and the whole brain. Gyriﬁcation
could not be estimated for 7 scans, because of FreeSurfer processing er-
rors. We also measured the volume of subcortical structures, as well as
subcortical gray matter volume and gray and white matter separately
for the cerebellum. In order to reduce within-subject variability be-
tween scan sessions, the longitudinal analysis processing pipeline of
FreeSurfer was used for subjects with more than one scan (Gogtay et
al., 2006; Reuter and Fischl, 2011).Manual editswere performed as nec-
essary by a trained rater (SdW) blind to subject identity and group
membership.
2.4. Statistical analyses
The statistical software package R version 2.14.0 was used (1) to test
for between-group differences in the demographic and clinical data and
(2) to investigate the effects of age, group and their interaction on the
brain measures using a linear mixed model. The mixed model proce-
dure investigated the relationship between age, group and our mea-
sures of interest (brain measures) using a top down selectionprocedure to test for the best-ﬁt growthmodel.Wewere particularly in-
terested in two effects: (1) main effects of group, where differences be-
tween groups were present at ﬁrst assessment and stable over
developmental time (range 12–24 years), and (2) group ∗ age interac-
tion effects where the developmental trajectories differed between
the groups (e.g. structure × increased over time in group A while it de-
creased over time in group B). Details of this model and selection proce-
dure are provided in Supplemental information S2.
3. Results
3.1. Between-group differences in demographic and clinical characteristics
Demographic and clinical characteristics of typically developing con-
trols and UHR individuals are provided in Table 1. Both groups were
matched for age, gender and number of scans. Hand preference and in-
tracranial volume did not differ between groups, but IQ was lower for
UHR individuals than for typically developing controls.
Demographic details of resilient and non-resilient individuals are
given in Table 2. The subgroups did not differ in terms of the use of psy-
chotropicmedication (Table 2). Our deﬁnition of resilience largely over-
laps with the deﬁnition as used in the classical deﬁnition based on
remission of UHR symptoms (see Supplemental information Tables S3
and S4): of 17 individuals classiﬁed as resilient based on functional out-
come, 12 were classiﬁed as being in remission; of 16 individuals classi-
ﬁed being in remission, 12 were classiﬁed as resilient based on
functional outcome. Of the ﬁve individuals classiﬁed as resilient based
on functional outcomebut not as being in remission, two had a psychot-
ic episode and later remitted with high mGAF scores at 6-year follow-
up. The other three still scored in the UHR range for positive symptoms,
but reported good functioning (mGAF scores between 70 and 80) at 6-
year follow-up. In clinical terms, resilience led to statistical improve-
ments on symptommeasures at follow-up, while there were few differ-
ences in symptoms at baseline.
3.2. Brain development in UHR compared to typical development
To allow comparison to earlier studies, we ﬁrst tested for differences
in brain development between the whole group of UHR individuals and
typically developing controls. In the cortex, we found the largest differ-
ences in cortical surface area. Here, we primarily found group ∗ age in-
teractions, with less steep decreases over developmental time in UHR
individuals in frontal and parietal areas compared to typically
Table 2
Demographic and clinical data of resilient (R) and non-resilient (NON-R) UHR individuals based on functional outcomea.
R NON-R R vs. NON-R
Number of individuals, n (males) 17 (13) 18 (10) n.s.
Premorbid IQ, mean (SD) 101.18 (12.89) 103.22 (10.28) n.s.
Age at baseline, years
Mean (SD) 15.42 (2.20) 15.54 (2.48) n.s.
Range 12.31–19.64 12.28–19.43
Age at 6-year FU, years
Mean (SD) 21.34 (2.58) 20.99 (2.32) n.s.
Range 17.88–25.79 16.84–24.80
SIPS/SOPS baseline, mean (SD)
Total score 21.35 (10.74) 25.06 (11.47) n.s.
Positive symptoms 7.41 (4.53) 8.50 (3.13) n.s.
Negative symptoms 4.24 (4.66) 4.17 (3.67) n.s.
Disorganized symptoms 3.41 (3.30) 5.89 (2.83) U= 68.0, p= 0.004
General symptoms 6.29 (4.33) 6.50 (4.51) n.s.
mGAF baseline, mean (SD) 57.06 (13.57) 56.83 (17.44) n.s.
SIPS/SOPS 6-year FU, mean (SD)
Total score 11.75 (8.36) 35.11 (14.11) U= 20.5, p ≤0.001
Positive symptoms 3.88 (3.59) 10.00 (5.54) U= 45.5, p ≤0.001
Negative symptoms 3.88 (3.72) 11.17 (5.79) U= 44.0, p ≤0.001
Disorganized symptoms 3.19 (2.74) 7.22 (3.37) t= 3.80, p= 0.001
General symptoms 1.50 (1.59) 6.72 (4.86) U= 42.0, p ≤0.001
mGAF 6-year FU, mean (SD) 77.94 (7.30) 47.50 (9.94) t=−10.27, p ≤0.001
Psychotropic medication baseline, any n.s.
No 9 9
Yes 8 9
Psychotropic medication 6-year FU, any n.s.
No 13 11
Yes 4 7
TDC= typically developing controls; UHR= Individuals at ultra-high risk for psychosis; R= resilience; NON-R=non-resilience; IQ= intelligence quotient; SD= standard deviation; FU
= follow-up; SIPS/SOPS = Structured Interview for Prodromal Symptoms/Scale of Prodromal Symptoms; mGAF = Modiﬁed Global Assessment of Functioning.
a Subgroups are based on outcome at 6-year FU; outcome was unknown for 13 UHR individuals.
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cortical volume, cortical thickness and gyriﬁcation. Furthermore, we
found that UHR individuals showed stable as well as steeper decreases
over developmental time in hippocampus (p=0.012/0.006) and thala-
mus volume (p = 0.015/0.022), as well as smaller volume at baseline
and steeper increases over developmental time in the volume of third
(p=0.019) and inferior lateral ventricle (p=0.049) than typically de-
veloping controls. All results are listed in Supplemental information S5.
3.3. Brain development in resilient versus non-resilient UHR individuals
Main effects of group and group ∗ age interaction effects of resilient
versus non-resilient individuals are shown in Fig. 2 and listed in Supple-
mental information S6. We additionally provided results from the anal-
yses using the classic operationalisation (remission from UHR criteria)
in Supplemental information S7. These were highly similar to those re-
ported in the main paper.
3.3.1. Stable differences between groups
There were widespread differences between resilient and non-resil-
ient UHR individuals that were stable over developmental time (i.e.,
main effects of group). Resilient individuals had larger volumes of
frontal, temporal and parietal cortex, corpus callosum and nucleus ac-
cumbens than non-resilient individuals (p= 0.003–0.025, see Supple-
mental information S4). Furthermore, overall cortical thickness was
larger for resilient compared to non-resilient individuals, mainly due
to increases in thickness in frontal, parietal and temporal lobes (p =
0.000–0.046). Cortical surface area was larger throughout the left hemi-
sphere and there were some differences in gyriﬁcation (p = 0.003–
0.042, see Supplemental information S4). When we added the trajecto-
ries of typically developing controls in these areas, we found that they
fell between those of resilient and non-resilient individuals. This is illus-
trated in the supplemental information where some of the graphs of
these trajectories are provided (S8).3.3.2. Developmental differences
There were some developmental differences between resilient
and non-resilient UHR individuals where developmental trajectories
diverged between groups over time (group ∗ age interactions; see
Fig. 3). Resilient individuals showed smaller decrease in volume
over developmental time in anterior cingulate gyrus (p = 0.049)
and smaller increase over developmental time in lateral ventricle
volume (p = 0.036). Furthermore, resilient individuals showed
greater decreases in cortical thickness in superior temporal cortex
(p = 0.038) and posterior cingulate gyrus (p = 0.011) than non-re-
silient individuals. Resilient individuals also showed increases over
developmental time in cortical surface area in precentral gyrus
(p = 0.037) and frontal pole (p = 0.033) compared to decreases in
non-resilient individuals. Finally, resilient individuals showed de-
creases in gyriﬁcation in anterior cingulate gyrus over developmen-
tal time compared to increases in non-resilient individuals (p =
0.049).4. Discussion
We investigated brain development over six years in a matched
sample of 48 adolescents at ultra-high risk for developing psychosis
and 48 typically developing controls, with up to three MRI scans per in-
dividual. Ourmain goal was to compare brain development between re-
silient and non-resilient UHR individuals.We operationalized resilience
as good functioning at 6-year follow-up, information that was available
for 35 of the UHR individuals. We found widespread differences in vol-
ume of frontal, temporal and parietal cortex that were already present
at baseline and remained stable over development. Furthermore, there
were differences between resilient and non-resilient individuals in the
development of cortical surface area in multiple frontal regions includ-
ing cingulate gyrus. These diverging developmental trajectoriesmay re-
ﬂect compensatory neural mechanisms, where the better functioning
resilient individuals results in less tissue loss with development.
Fig. 2. Differences in cortical morphology between resilient and non-resilient UHR individuals.
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uals and typically developing volunteers, we found diverging develop-
mental trajectories for cortical surface area in frontal and parietal
regions. Here, typically developing controls showed greater decreases
over development than UHR individuals. Furthermore, we found de-
creases in hippocampus and thalamus volume and increases in the vol-
ume of the third and inferior lateral ventricles in UHR individuals that
were already present at baseline. These ﬁndings are in keeping with
other studies on psychosis and UHR (for reviews, see Fusar-Poli et al.,
2011, 2012b; Wood et al., 2013; Bois et al., 2014).
When we compared brain development between resilient and non-
resilient UHR individuals, we found three types of changes: First, there
were differences that were already present at baseline and that were
stable over development, with the developmental trajectories parallel
for both groups. These included greater cortical thickness and cortical
volume and larger volume of the nucleus accumbens and corpus
callosum in resilient individuals. Interestingly, when we added the tra-
jectories of typically developing controls in these areas, we found that
they fell between those of resilient and non-resilient individuals (see
Supplemental information S6). As such, the volume of resilient individ-
uals exceeded that of typically developing volunteers, one possible
mechanism that may be at play is that the greater volume may be pro-
tective for worse outcome, including less tissue loss. In addition, these
volumetric differences might be a predictive marker of good outcome.
Earlier longitudinal studies of development in UHR individualsprimarily focused on transition to psychosis. Most of these have
shown differences between UHR individuals with different clinical out-
comes in insular, temporal, parietal and superior frontal regions
(Fornito et al., 2008; Sun et al., 2009; Ziermans et al., 2012; Wood et
al., 2013). One study investigated differences in baseline gray matter
volume between non-transitioned individuals with and without persis-
tent attenuated positive symptoms and found differences in frontal,
temporal, posterior and cingulate regions (Cropley et al., 2016). These
regions highly overlap with our results. Our data suggest that these re-
gions may hold promise for predicting, at a young age, which UHR indi-
viduals will get better and which will worsen over time. This was also
suggested by Cropley et al. (2016).
A second pattern in our data is developmental trajectories that over-
lap at young age but diverge over developmental time. Areas showing
this pattern include precentral gyrus, frontal pole, anterior cingulate
gyrus and lateral ventricle (see Fig. 3). The enlargement of lateral ventri-
cles was one of the ﬁrst brain ﬁndings to be reported in schizophrenia
and is still one of the most consistently reported (Shenton et al.,
2001). In our study, the volume of lateral ventricles increased more
over development for non-resilient individuals than for resilient ones.
The anterior cingulate gyrus showed decreases in volume over develop-
ment for both resilient and non-resilient individuals. However, its vol-
ume stabilized in early adulthood for resilient individuals, whereas it
continued to decrease in the non-resilient group. This structure is im-
portant for goal-directed behavior and involved in error and conﬂict
Fig. 3. Distinct developmental trajectories between resilient and non-resilient UHR individuals.
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548 S. de Wit et al. / NeuroImage: Clinical 12 (2016) 542–549monitoring and has often been reported to show changes in structure
and function in UHR and schizophrenia (Fornito et al., 2008, 2009; Reid
et al., 2010). The stabilization in the resilient group may reﬂect neural
changes as a result of recovery in this group, whereas the continuing
loss of volume in non-resilient individuals may reﬂect their continuing
difﬁculties with cognitive and emotional integration (Fornito et al.,
2008, 2009). The left precentral gyrus and right frontal pole showed de-
velopmental increases in surface area in resilient individuals compared
to slight decreases in non-resilient individuals. Changes in frontal areas
have often been associated with UHR and schizophrenia (for review,
seeWood et al., 2013). As such, these increases may also represent com-
pensatory mechanisms, related to better functioning in resilience. Other
structures, such as the posterior cingulate and superior temporal gyrus,
showed converging trajectories, where baseline differences disappeared
with development. Interestingly, both resilient andnon-resilient individ-
uals showed decreases over development in cortical thickness in these
areas, similar to what is seen in typical development. However, the
non-resilient group showed a slower rate of change than the resilient
group. These ﬁndings concur with a study by Zalesky et al. (2015):
these authors reportedmaturational delays in cortical thickness in child-
hood onset schizophrenia, and normalization of these changes over de-
velopment for those subjects who showed symptomatic improvement.
Finally, there were brain areas that differed between UHR individ-
uals and typically developing controls, but not between resilient and
non-resilient UHR individuals. These included hippocampus, thalamus
and frontal and parietal cortical surface area. These changes are unlikely
to be useful for predicting long-term functioning in UHR individuals, as
they do not differ between resilient and non-resilient individuals. Rath-
er, theymay be related to non-speciﬁc UHR risk factors, such as obstetric
complications (Stefanis et al., 1999; Wood et al., 2008).
In our supplementalmaterials, we have included the results of a sec-
ond analysis where we compared those UHR individuals who had re-
mitted from their UHR status to those who had not. The results from
this analysis were similar but noisier (see Supplemental information
S7). The biggest difference was found for gyriﬁcation: while there
were few differences in gyriﬁcation found with the operationalisation
based on functional outcome, more were found with the analysis
using remission from UHR criteria. This might suggest that differences
in gyriﬁcation are more speciﬁc to positive symptoms than global func-
tioning. We chose to present the results from the operationalisation
based on functional outcome as we felt that was the deﬁnition with
the most clinical relevance. Hence, when interpreting the results, we
should keep inmind that themain ﬁndings of this paper relate to global
functioning.
There are some limitations to this study. First is the relativelymodest
sample size, especially for the follow-up analyses on resilience (17 ver-
sus 18 subjects). This is in part because itwas necessary to exclude some
subjects from these analyses to match subgroups for gender and age.
We felt it was important to maintain this matching given the skewed
distribution of gender in UHR and schizophrenia (McGrath et al.,
2008;Walder et al., 2013; Cocchi et al., 2014) and ﬁndings of gender dif-
ferences in brain size and development (Lenroot et al., 2007; Wierenga
et al., 2014). The limited sample size means we may have been under-
powered to detect subtle differences, andmay be causal to the relatively
small number of developmental changes found. On the other hand, lon-
gitudinal samples require far fewer participants than cross-sectional
studies in order to detect small differences in brain structure. Steen
and colleagues showed that the required sample to detect a 5% differ-
ence in whole brain volume is 73 patients and 73 typically developing
controls in a 2-sample cross-sectional study, against just 5 patients
and 5 typically developing controls in a longitudinal study design
(Steen et al., 2007). Moreover, we were able to report longitudinal
data with more than two MRI scans per individual, potentially permit-
ting us to ﬁt more complex developmental models to the data.
A second limitation is that a large number of UHR individuals were
on medication for the duration of this study. This is often the case inUHR studies and one can argue that medication may have been pre-
scribed for individuals who were clinically more severely affected, or
that it may have helped prevent the onset of psychosis. However, med-
ication use did not differ between resilient and non-resilient individuals,
not at baseline or at follow-up. This suggests thatmedication use did not
overly inﬂuence our results. The lack of a difference between resilient
and non-resilient individuals could even be taken to suggest that med-
ication does not play a role in individual outcome, although the sample
size is too modest to permit any such deﬁnitive conclusion.
In conclusion, brain development in resilient individuals initially at
UHR for psychosis differs from that of non-resilient individuals. Wide-
spread differences in cortical thickness and volume were evident at
baseline and remained stable over development. However, several fron-
tal areas showed diverging developmental trajectories. The stable dif-
ferences that were already present at baseline may hold promise for
predicting, at a young age, who will go on to recover and who will
not, whereas the divergence in frontal areas may reﬂect neural changes
related to better functioning.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.nicl.2016.08.013.Acknowledgements
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